Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
2.660
+0.200 (8.13%)
At close: Jan 30, 2026, 4:00 PM EST
2.724
+0.064 (2.41%)
After-hours: Jan 30, 2026, 7:59 PM EST
Genprex Market Cap
Genprex has a market cap or net worth of $6.17 million as of January 30, 2026. Its market cap has decreased by -1.76% in one year.
Market Cap
6.17M
Enterprise Value
5.06M
1-Year Change
-1.76%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $6.17M, a decrease of -89.93%. That is a compound annual growth rate of -25.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 5.70M | 40.57% |
| Dec 31, 2025 | 4.06M | -43.99% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 6.23M |
| Alaunos Therapeutics | 6.14M |
| Silexion Therapeutics | 6.13M |
| Bio Green Med Solution | 6.03M |
| Can-Fite BioPharma | 5.94M |
| Adial Pharmaceuticals | 5.93M |
| Acurx Pharmaceuticals | 5.86M |
| Xenetic Biosciences | 5.34M |